1 |
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8):801.
|
2 |
Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014 [J]. JAMA, 2017, 318(13):1241.
|
3 |
Marx G. Incidence of severe sepsis and septic shock in german intensive care units - the insep study [J]. Intensive Care Med Exp, 2015, 3(S1):1.
|
4 |
Liu XW, Ma T, Liu W, et al. Sustained increase in angiopoietin-2, heparin-binding protein, and procalcitonin is associated with severe sepsis [J]. J Crit Care, 2018, 45:14-19.
|
5 |
Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice [J]. Science, 1999, 285(5425):248-251.
|
6 |
Cai B, Deitch EA, Ulloa L. Novel insights for systemic inflammation in sepsis and hemorrhage [J]. Mediators Inflamm, 2010, 2010:642462.
|
7 |
Bosmann M, Ward PA. The inflammatory response in sepsis [J]. Trends Immunol, 2013, 34(3):129-136.
|
8 |
van der Poll T, van de Veerdonk FL, Scicluna BP, et al. The immunopathology of sepsis and potential therapeutic targets [J]. Nat Rev Immunol, 2017, 17(7):407-420.
|
9 |
Wiersinga WJ, Leopold SJ, Cranendonk DR, et al. Host innate immune responses to sepsis [J]. Virulence, 2014, 5(1):36.
|
10 |
Meakins JL, Pietsch JB, Bubenick O, et al. Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma [J]. Ann Surg, 1977, 186(3):241-250.
|
11 |
Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure [J]. JAMA, 2011, 306(23):2594-2605.
|
12 |
Otto GP, Sossdorf M, Claus RA, et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate [J]. Crit Care, 2011, 15(4):R183.
|
13 |
Bao Q, Lv R, Lei M. IL-33 attenuates mortality by promoting IFN-γ production in sepsis [J]. Inflamm Res, 2018, 67(6):531-538.
|
14 |
Unsinger J, Mcglynn M, Kasten KR, et al. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis [J]. J Immunol, 2010, 184(7):3768.
|
15 |
Chang KC, Burnham CA, Compton SM, et al. Blockade ofthe negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis [J]. Crit Care, 2013, 17(3):R85.
|
16 |
Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity [J]. Int J Cancer, 1975, 16(2):216-229.
|
17 |
Campbell KS, Hasegawa J. Natural killer cell biology: an update and future directions [J]. J Allergy Clin Immunol, 2013, 132(3):536-544.
|
18 |
Smyth MJ, Cretney E, Kelly JM, et al. Activation of NK cell cytotoxicity [J]. Mol Immunol, 2005, 42(4):501.
|
19 |
刘杜姣,贾金虎,薛庆亮. NK细胞与脓毒血症的相关性研究进展 [J]. 世界中西医结合杂志, 2015, 10(2):284-286.
|
20 |
Guo Y, Patil NK, Luan L, et al. The biology of natural killer cells during sepsis [J]. Immunology, 2018, 153(2):190-192.
|
21 |
周光炎. 免疫学原理[M]. 上海: 上海科学技术出版社, 2007.
|
22 |
周静,彭慧,田志刚. NK细胞负向调控适应性免疫应答研究进展 [J]. 中国免疫学杂志, 2016, 32(6):769-776.
|
23 |
O′Leary JG, Goodarzi M, Drayton DL, et al. T cell- and B cell-independent adaptive immunity mediated by natural killer cells [J]. Nat Immunol, 2006, 7(5):507-516.
|
24 |
Paust S, Gill HS, Wang BZ, et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses [J]. Nat Immunol, 2010, 11(12):1127-1135.
|
25 |
Béziat V, Dalgard O, Asselah T, et al. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients [J]. Eur J Immunol, 2012, 42(2):447-457.
|
26 |
Brunetta E, Fogli M, Varchetta S, et al. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection [J]. Aids, 2010, 24(1):27-34.
|
27 |
Gumá M, Budt M, Sáez A, et al. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts [J]. Blood, 2006, 107(9):3624-3631.
|
28 |
Björkström NK, Therese L, Malin S, et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus [J]. J Exp Med, 2011, 208(1):13-21.
|
29 |
Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells [J]. Nature, 2009, 457(7229):557.
|
30 |
Cooper MA, Elliott JM, Keyel PA, et al. Cytokine-induced memory-like natural killer cells [J]. Proc Natl Acad Sci U S A, 2009, 106(6):1915-1919.
|
31 |
Keppel MP, Yang L, Cooper MA. Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation [J]. J Immunol, 2013, 190(9):4754-4762.
|
32 |
Gillard GO, Bivas-benita M, Hovav AH, et al. Thy1+ NK cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes [J]. PLoS Pathog, 2011, 7(8):e1002141.
|
33 |
Souzafonsecaguimaraes F, Parlato M, Philippart F, et al. Toll-like receptors expression and interferon-γ production by NK cells in human sepsis [J]. Crit Care, 2012, 16(5):R206.
|
34 |
Hiraki S, Ono S, Kinoshita M, et al. Neutralization of IL-10 restores the downregulation of IL-18 receptor on natural killer cells and interferon-γ production in septic mice, thus leading to an improved survival [J]. Shock, 2012, 37(2):177.
|
35 |
Chiche L, Forel JM, Thomas G, et al. The role of natural killer cells in sepsis [J]. J Biomed Biotechnol, 2011, 2011:986491.
|
36 |
Hotchkiss RS, Chang KC, Grayson MH, et al. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis [J]. Proc Natl Acad Sci U S A, 2003, 100(11):6724-6729.
|
37 |
Inoue S, Unsinger JC. IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis [J]. J Immunol, 2010, 184(3):1401-1409.
|
38 |
Guo Y, Luan L, Patil NK, et al. IL-15 enables septic shock by maintaining NK cell integrity and function [J]. J Immunol, 2017, 198(3):1320-1333.
|
39 |
Pablo RD, Monserrat J, Torrijos C, et al. The predictive role of early activation of natural killer cells in septic shock [J]. Crit Care, 2012, 16(2):413.
|